- Home
- ECOR vs MDCX Comparison
ECOR vs MDCX Comparison
Compare ECOR & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- MDCX
- Stock Information
- Founded
- ECOR 2005
- MDCX 2008
- Country
- ECOR United States
- MDCX Canada
- Employees
- ECOR N/A
- MDCX N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- MDCX
- Sector
- ECOR Health Care
- MDCX
- Exchange
- ECOR Nasdaq
- MDCX Nasdaq
- Market Cap
- ECOR 37.1M
- MDCX 36.2M
- IPO Year
- ECOR 2018
- MDCX N/A
- Fundamental
- Price
- ECOR $4.96
- MDCX $2.05
- Analyst Decision
- ECOR Strong Buy
- MDCX Strong Buy
- Analyst Count
- ECOR 2
- MDCX 2
- Target Price
- ECOR $25.50
- MDCX $23.50
- AVG Volume (30 Days)
- ECOR 99.3K
- MDCX 410.9K
- Earning Date
- ECOR 08-06-2025
- MDCX 08-11-2025
- Dividend Yield
- ECOR N/A
- MDCX N/A
- EPS Growth
- ECOR N/A
- MDCX N/A
- EPS
- ECOR N/A
- MDCX N/A
- Revenue
- ECOR $27,700,000.00
- MDCX N/A
- Revenue This Year
- ECOR $24.48
- MDCX N/A
- Revenue Next Year
- ECOR $44.35
- MDCX N/A
- P/E Ratio
- ECOR N/A
- MDCX N/A
- Revenue Growth
- ECOR 30.16
- MDCX N/A
- 52 Week Low
- ECOR $4.16
- MDCX $1.79
- 52 Week High
- ECOR $19.49
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- ECOR 41.18
- MDCX 46.56
- Support Level
- ECOR $4.74
- MDCX $1.79
- Resistance Level
- ECOR $5.32
- MDCX $2.11
- Average True Range (ATR)
- ECOR 0.34
- MDCX 0.21
- MACD
- ECOR 0.00
- MDCX 0.02
- Stochastic Oscillator
- ECOR 22.22
- MDCX 42.03
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.